Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 4, 2007, Pages 496-501

  Gambarin Gelwan, Maya ^a   Kinkhabwala, Sanjiv V ^b   Schiano, Thomas D ^c   Bodian, Carol ^c   Yeh, Hsu Chong ^c   Futterweit, Walter ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN;

ADULT; ANAMNESIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEIGHT; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MEDICAL RECORD; NONALCOHOLIC FATTY LIVER; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PREVALENCE; RETROSPECTIVE STUDY; WEIGHT;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COMORBIDITY; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 34147168713     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.10.010     Document Type: Article

References (44)

1. Clark J.M., and Diehl A.M. Nonalcoholic fatty liver disease: an under-recognized cause of cryptogenic cirrhosis. JAMA 289 (2003) 3000-3004
2. Caldwell S.H., Oelsner D.H., Iezzoni J.C., et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 (1999) 664-669
3. Poonawala A., Nair S.P., and Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32 (2000) 689-692
4. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterology 98 (2003) 960-967
5. Ruhl C., and Everhart J. Determinations of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124 (2003) 71-79
6. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 16 (2002) 1221-1231
8. Farell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 Suppl 1 (2006) S99-S112
9. Beymer C., Kowdley K.V., Larson A., et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg 138 (2003) 1240-1244
10. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
11. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123 (2002) 134-140
12. Ong J.P., and Younossi Z.M. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?. Gastroenterology 123 (2002) 375-378
13. Friis-Liby I., Aldenborg F., Jerlstad P., et al. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 39 (2004) 868-869
14. Marchesini G., Brizi M., Bianchi G., et al. Non-alcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
15. Angelico F., Del Ben M., Conti R., et al. Insulin resistance, the metabolic syndrome, and non-alcoholic fatty liver disease. J Clin Endocrinol Metab 90 (2005) 1578-1582
16. Kim H.J., Kim H.J., Kwang E.L., et al. Metabolic significance of non-alcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164 (2004) 2169-2175
17. Knochenhauer E.S., Key T.J., Kahsar-Miller M., et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
18. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84 (1999) 4006-4011
19. Asunción M., Calvo R.M., San Milan J.L., et al. A prospective study of the prevalence of polycystic ovary syndrome from Spain. J Clin Endocrinol Metab 85 (2000) 2434-2438
20. Azziz R., Yildiz B., Woods K.S., et al. The prevalence of polycystic ovary syndrome among unselected consecutive premenopausal women. J Clin Endocrinol Metab 89 (2004) 2745-2749
21. Carmina E., Legro R.S., Stamets K., et al. Difference in body weight between American and Italian women with polycystic ovary syndrome. Human Reprod 18 (2003) 2289-2293
22. Schwimmer J.B., Khorram O., Chiu V., et al. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fert Steril 83 (2005) 494-497
23. Brown A.J., Tendler D.A., McMurray R.G., et al. Polycystic ovary syndrome with nonalcoholic steatohepatitis: beneficial effects of modest weight loss and exercise on liver biopsy findings. Endocr Pract 11 (2005) 319-324
24. Setji T.L., Holland N.D., Sanders L.L., et al. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 1741-1747
25. Zawadsky J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F.P., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific Publications, Boston 377-384
26. Scatarige J.C., Scott W.W., Donovan P.J., et al. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 3 (1984) 9-14
27. World Health Organization. Obesity: preventing and managing the global epidemic: WHO/NUT/98.1 (1998), World Health Organization, Geneva, Switzerland
28. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting to plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
29. Shen L., Fan J.-G., Shao Y., et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiologic survey. World J Gastroenterol 9 (2003) 1106-1110
30. Singh S.P., Nayak S., Swain M., et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 25 (2004) 76-79
31. Omagari K., Kadokawa Y., Masuda J.-I., et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 17 (2002) 1098-1105
32. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 132 (2000) 112-117
33. Mofrad P., Contos M.J., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37 (2003) 1286-1292
34. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
35. Carmina E., and Lobo R.A. Do hyperandrogenic women with normal menses have polycystic ovary syndrome?. Fertil Steril 71 (1999) 319-322
36. Carmina E., and Lobo R.A. Polycystic ovaries in hirsute women with normal menses. Am J Med 111 (2001) 602-606
37. Eriksson S., Eriksson K.F., and Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 220 (1986) 83-88
38. Robinson S., Kiddy D., Gelding S.V., et al. The relationship of insulin sensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 39 (1993) 351-355
39. Graif M., Yanuka M., Baraz M., et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 35 (2000) 319-324
40. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
41. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
42. Ratziu V., Giral P., Charlotte F., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
43. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21 (2001) 3-16
44. Sorrentino P., Tarantino G., Conca P., et al. Silent non-alcoholic fatty liver disease: a clinical-histological study. J Hepatol 41 (2004) 751-757